Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression
- PMID: 21566516
- DOI: 10.1097/PAS.0b013e3182196a39
Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression
Abstract
Atypical teratoid/rhabdoid tumors (AT/RTs) are highly aggressive brain tumors of early childhood poorly responding to therapy. The majority of cases show inactivation of SMARCB1 (INI1, hSNF5, BAF47), a core member of the adenosine triphosphate (ATP)-dependent SWI/SNF chromatin-remodeling complex. We here report the case of a supratentorial AT/RT in a 9-month-old boy, which showed retained SMARCB1 staining on immunohistochemistry and lacked genetic alterations of SMARCB1. Instead, the tumor showed loss of protein expression of another SWI/SNF chromatin-remodeling complex member, the ATPase subunit SMARCA4 (BRG1) due to a homozygous SMARCA4 mutation [c.2032C>T (p.Q678X)]. Our findings highlight the role of SMARCA4 in the pathogenesis of SMARCB1-positive AT/RT and the usefulness of antibodies directed against SMARCA4 in this diagnostic setting.
Similar articles
-
Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).Neuropathology. 2018 Jun;38(3):305-308. doi: 10.1111/neup.12452. Epub 2017 Dec 21. Neuropathology. 2018. PMID: 29271065
-
Rhabdoid tumor predisposition syndrome.Pediatr Dev Pathol. 2015 Jan-Feb;18(1):49-58. doi: 10.2350/14-07-1531-MISC.1. Epub 2014 Dec 10. Pediatr Dev Pathol. 2015. PMID: 25494491
-
Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome.Am J Hum Genet. 2010 Feb 12;86(2):279-84. doi: 10.1016/j.ajhg.2010.01.013. Epub 2010 Feb 4. Am J Hum Genet. 2010. PMID: 20137775 Free PMC article.
-
Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy.Pediatr Hematol Oncol. 2013 Oct;30(7):587-604. doi: 10.3109/08880018.2013.791737. Epub 2013 Jul 12. Pediatr Hematol Oncol. 2013. PMID: 23848359 Review.
-
Intracranial atypical teratoid/rhabdoid tumor presenting as an axillary mass: a case report and review of literature.Pediatr Dev Pathol. 2014 Mar-Apr;17(2):122-5. doi: 10.2350/14-01-1427-CR.1. Epub 2014 Feb 20. Pediatr Dev Pathol. 2014. PMID: 24555876 Review.
Cited by
-
Outcomes for children with recurrent/refractory atypical teratoid rhabdoid tumor: A single-institution study with molecular correlation.Pediatr Blood Cancer. 2024 Oct;71(10):e31208. doi: 10.1002/pbc.31208. Epub 2024 Jul 21. Pediatr Blood Cancer. 2024. PMID: 39034595
-
Interrogation of Mammalian Protein Complex Structure, Function, and Membership Using Genome-Scale Fitness Screens.Cell Syst. 2018 May 23;6(5):555-568.e7. doi: 10.1016/j.cels.2018.04.011. Epub 2018 May 16. Cell Syst. 2018. PMID: 29778836 Free PMC article.
-
Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.J Neurooncol. 2014 Sep;119(2):343-51. doi: 10.1007/s11060-014-1484-4. Epub 2014 May 31. J Neurooncol. 2014. PMID: 24879375
-
Loss of Smarc proteins impairs cerebellar development.J Neurosci. 2014 Oct 1;34(40):13486-91. doi: 10.1523/JNEUROSCI.2560-14.2014. J Neurosci. 2014. PMID: 25274825 Free PMC article.
-
An analysis of the diagnosis, clinical characteristics, treatment, and survival outcomes of 36 extracranial malignant rhabdoid tumor patients.Transl Pediatr. 2021 Jun;10(6):1598-1609. doi: 10.21037/tp-20-459. Transl Pediatr. 2021. PMID: 34295774 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous